Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng-Gee Lim

Showing results (171-180 of 219) with videos related to

Pageof 22
Sort By:
The Lancet. Gastroenterology & Hepatology|June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statementGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
Digestive Diseases (Basel, Switzerland)|September 13, 2023
Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and FemalesDarren Tan, Kai En Chan, Zhen Yu Wong, et al.
Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Hepatology International|July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Gut|July 8, 2015
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionChoong Tat Keng, Ching Wooen Sze, Dahai Zheng, et al.
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation studyYu Jun Wong, Guan Sen Kew, Poh Seng Tan, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
Pageof 22

Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
The Lancet. Gastroenterology & Hepatology|June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statementGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.
Digestive Diseases (Basel, Switzerland)|September 13, 2023
Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and FemalesDarren Tan, Kai En Chan, Zhen Yu Wong, et al.
Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Hepatology International|July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Gut|July 8, 2015
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionChoong Tat Keng, Ching Wooen Sze, Dahai Zheng, et al.
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation studyYu Jun Wong, Guan Sen Kew, Poh Seng Tan, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
Pageof 22